Prioritization and environmental risk assessment of pharmaceuticals mixtures from Brazilian surface waters
Eduarda O Reis1, Lucilaine V S Santos2, Liséte C Lange3
1Department of Sanitary and Environmental Engineering, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Federal Institute of Education, Science and Technology of South of Minas Gerais -IFSULDEMINAS, Inconfidentes, Minas, Gerais, Brazil.
Abstract:
The present study provides an environmental risk assessment of the pharmaceutical mixtures detected in Brazilian surface waters, based on Toxic Units and Risk Quotients. Furthermore, the applicability of a previously proposed prioritization methodology was evaluated. The pharmaceuticals were classified according to their properties (occurrence, persistence, bioaccumulation, and toxicity) and the contribution of the prioritized compounds to the mixture risk was determined. The mixture risk quotients, based on acute and chronic toxicity data, often exceed 1, demonstrating a potential risk for the environment. While algae were most affected by acute effects, fish were the most sensitive organism to sublethal effects. The lipid regulator atorvastatin was the main driver for the mixture risk. Despite their lower occurrence, the antibiotics norfloxacin and enrofloxacin were critical compounds for the algae group. The prioritized pharmaceuticals contributed to more than 75% of the mixture risk in most of cases, indicating the applicability of prioritization approaches for risk management.
More Related Videos
09:49Prospecting Microbial Strains for Bioremediation and Probiotics Development for Metaorganism Research and Preservation
Published on: October 31, 2019
08:20Systematic Approach to Identify Novel Antimicrobial and Antibiofilm Molecules from Plants' Extracts and Fractions to Prevent Dental Caries
Published on: March 31, 2021
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Regulation
Factors Influencing Drug Absorption: Pharmaceutical Parameters
